BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12679805)

  • 21. Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity.
    Hwang KS; Cho WK; Yoo J; Seong YR; Kim BK; Kim S; Im DS
    Cancer Gene Ther; 2004 Jun; 11(6):397-407. PubMed ID: 15044962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.
    Lee YS; Kim JH; Choi KJ; Choi IK; Kim H; Cho S; Cho BC; Yun CO
    Clin Cancer Res; 2006 Oct; 12(19):5859-68. PubMed ID: 17020994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensification of antitumor effect by T helper 1-dominant adoptive immunogene therapy for advanced orthotopic colon cancer.
    Nakamori M; Iwahashi M; Nakamura M; Ueda K; Zhang X; Yamaue H
    Clin Cancer Res; 2003 Jun; 9(6):2357-65. PubMed ID: 12796406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cell-mediated immune response induced by plasmid encoding bovine herpesvirus 1 glycoprotein B is enhanced by plasmid encoding IL-12 when delivered intramuscularly or by gene gun, but not after intradermal injection.
    Huang Y; Babiuk LA; van Drunen Littel-van den Hurk S
    Vaccine; 2006 Jun; 24(25):5349-59. PubMed ID: 16714071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma.
    Nakano H; Kishida T; Asada H; Shin-Ya M; Shinomiya T; Imanishi J; Shimada T; Nakai S; Takeuchi M; Hisa Y; Mazda O
    J Gene Med; 2006 Jan; 8(1):90-9. PubMed ID: 16097036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor effects of interleukin-18 gene-modified hepatocyte cell line on implanted liver carcinoma.
    Leng J; Zhang L; Yao H; Cao X
    Chin Med J (Engl); 2003 Oct; 116(10):1475-9. PubMed ID: 14570604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined IL-12 and GM-CSF gene therapy for murine hepatocellular carcinoma.
    Wang Z; Qiu SJ; Ye SL; Tang ZY; Xiao X
    Cancer Gene Ther; 2001 Oct; 8(10):751-8. PubMed ID: 11687898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroid cancer immuno-therapy with retroviral and adenoviral vectors expressing granulocyte macrophage colony stimulating factor and interleukin-12 in a rat model.
    Tanaka K; Towata S; Nakao K; Mizuguchi H; Hayakawa T; Niwa M; Ishii N; Nagayama Y
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):734-42. PubMed ID: 14974915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of angiogenesis by naked DNA IL-12 gene transfer: angioprevention by immunogene therapy.
    Morini M; Albini A; Lorusso G; Moelling K; Lu B; Cilli M; Ferrini S; Noonan DM
    Gene Ther; 2004 Feb; 11(3):284-91. PubMed ID: 14737088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A safety and efficacy study of local delivery of interleukin-12 transgene by PPC polymer in a model of experimental glioma.
    Sonabend AM; Velicu S; Ulasov IV; Han Y; Tyler B; Brem H; Matar MM; Fewell JG; Anwer K; Lesniak MS
    Anticancer Drugs; 2008 Feb; 19(2):133-42. PubMed ID: 18176109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early events of electroporation-mediated intramuscular DNA vaccination potentiate Th1-directed immune responses.
    Grønevik E; Mathiesen I; Lømo T
    J Gene Med; 2005 Sep; 7(9):1246-54. PubMed ID: 15822067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene-gun particle with pro-opiomelanocortin cDNA produces analgesia against formalin-induced pain in rats.
    Lu CY; Chou AK; Wu CL; Yang CH; Chen JT; Wu PC; Lin SH; Muhammad R; Yang LC
    Gene Ther; 2002 Aug; 9(15):1008-14. PubMed ID: 12101431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seeing the gene therapy: application of gene gun technique to transfect and decolour pigmented rat skin with human agouti signalling protein cDNA.
    Yang CH; Shen SC; Lee JC; Wu PC; Hsueh SF; Lu CY; Meng CT; Hong HS; Yang LC
    Gene Ther; 2004 Jul; 11(13):1033-9. PubMed ID: 15164092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune modulation in cancer using DNA inoculation--antitumour effect of interleukin-12.
    Schultz J; Pavlovic J; Moelling K
    Dev Biol (Basel); 2000; 104():109-14. PubMed ID: 11713808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The systemic administration of Ig-4-1BB ligand in combination with IL-12 gene transfer eradicates hepatic colon carcinoma.
    Xu DP; Sauter BV; Huang TG; Meseck M; Woo SL; Chen SH
    Gene Ther; 2005 Oct; 12(20):1526-33. PubMed ID: 15973445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cotransduction of CCL27 gene can improve the efficacy and safety of IL-12 gene therapy for cancer.
    Gao JQ; Kanagawa N; Motomura Y; Yanagawa T; Sugita T; Hatanaka Y; Tani Y; Mizuguchi H; Tsutsumi Y; Mayumi T; Okada N; Nakagawa S
    Gene Ther; 2007 Mar; 14(6):491-502. PubMed ID: 17203106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-12 cDNA direct injection: antimetastatic effect from a single injection in a murine hepatic metastases model.
    Weber SM; Qi C; Neal Z; Sondel P; Mahvi DM
    J Surg Res; 2004 Dec; 122(2):210-7. PubMed ID: 15555620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of interleukin-12p40 gene transfer on rat corneal allograft survival.
    Ritter T; Yang J; Dannowski H; Vogt K; Volk HD; Pleyer U
    Transpl Immunol; 2007 Nov; 18(2):101-7. PubMed ID: 18005852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma.
    Hu P; Hu HD; Chen M; Peng ML; Tang L; Tang KF; Matsui M; Belladonna ML; Yoshimoto T; Zhang DZ; Xiang R; Ren H
    Mol Immunol; 2009 May; 46(8-9):1654-62. PubMed ID: 19299021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.